GLP-1 Commentary

Mobile World Congress (MWC) Barcelona 2025

About this Podcast

Jeff Jonas gives GabelliTV the scoop on GLP-1 Drugs and comments on how they might affect investing.

To learn more about Gabelli Funds’ fundamental, research-driven approach to investing, visit https://m.gabelli.com/gtv_cu or email invest@gabelli.com.

Connect with Gabelli Funds:
• Twitter – https://twitter.com/InvestGabelli
• Instagram – https://www.instagram.com/investgabelli/
• Facebook – https://www.facebook.com/InvestGabelli
• LinkedIn – https://www.linkedin.com/company/investgabelli/

http://www.Gabelli.com
Invest with Us 1-800-GABELLI (800-422-3554)

More Episodes

Investment Opportunities in Japan

Sound Opportunities: Growth in the Hearing Aid Market

Diageo Market News and Investment Insights

A Dive Into the Recent Findings from Keeley-Teton’s Semi-Annual Dividend Tracker 2023

Deals, Deals y más Deals

FDA Approval of Eli Lilly’s Tirzepatide Weighs on Competitors

Charlie LaRosa: On the Markets October 2023